Polymorphisms in TNF-α and IL-6 genes [48], as well higher levels of these markers and of CXCL10 [49] were linked to malaria clinical outcomes and pro-inflammatory activation in response to P. vivax [50]. The gene discussed is CXCL10; the disease is malaria.